The Johnson & Johnson Brand Family

Total Page:16

File Type:pdf, Size:1020Kb

The Johnson & Johnson Brand Family Advertising Age | January 28, 2008 | 37 The Johnson & Johnson brand family been greenlighted by J&J execu- tives got deep-sixed by Pfizer Though consumer-health and personal-care products make up only 24% of J&J’s $61 billion in annual sales, they account J&J managers last year, according to for about three-quarters of Johnson & Johnson’s $1.3 billion in annual measured U.S. media spending. Pharmaceuticals From Page 1 people familiar with the company. and medical devices, which make up about a third of the company, account for the rest, in categories with little direct-to- more costly this year. A $16.6 bil- “Even with perfect 20-20 hind- consumer advertising traditionally. lion acquisition has brought with it sight,” Mr. Perkins said, J&J a Pfizer culture that hasn’t would have sat out the upfront embraced change as readily as and will again. “For reasons I can’t MEASURED already-conservative incumbent get into, we’re really pleased with MEDIA management. Add in a big restruc- how this is playing out,” he said. SPENDING turing and as many as 4,500 job “We have worked closely with the IN MILLIONS losses amid the impending patent networks. And we really feel that expirations of big pieces of J&J’s we’re delivering the best kinds of prescription-drug and medical- opportunities for our brands by device business, and it’s just the coinciding with our planning BRAND 1 JOHNSON’S BABY sort of environment that sends schedule, not somebody else’s.” NEUTROGENA AVEENO TYLENOL LISTERINE & SKIN CARE many revolutionaries scurrying A J&J spokesman said, “We’re back to basics—i.e., the security of delighted with how well the whole JAN.-SEPT. ’07 $ $ $ $ $ tried-if-tired approaches. Pfizer consumer integration is 142.5 100.2 94.9 81.5 53.1 It’s up to the relatively small going, and we’re as pleased with the 2006 $ $ $ $ $ crew in the central marketing people as we are with the products.” 152.0 109.4 166.7 99.5 78.3 group piloting the $61 billion But even some of the seeming behemoth and its $1.3 billion U.S. successes of J&J’s modernization CREATIVE ROBERTS DDB DEUTSCH JWT LOWE media outlay to prove it can keep efforts have faced some doubts. AGENCY & TARLOW the reform movement aloft amid One of the bolder moves growing turbulence—and doubts. pushed by J&J’s central marketing Not often does a company try- group, in this case VP-Global ing to make substantial marketing Advertising and Marketing Joe changes face the host of challenges McCarthy, was naming independ- J&J does, said Rex Briggs, co- ent Mother, New York, to J&J’s author of the book “What Sticks,” roster to handle newly acquired and CEO of Marketing Evolution. oral-care brand Rembrandt. “J&J has some of the smartest peo- Mother got conservative J&J to ple I know in marketing, and I’m go along with some offbeat hoping they’ll continue to be a approaches, including a retro pack- BRAND beacon for others,” he said. “But aging overhaul, a pop-up store in BENADRYL TOPAMAX K-Y SUDAFED CLEAN & CLEAR I’m worried that with all the SoHo and a YouTube video fea- things going on, how much can turing a passionate kiss that’s JAN.-SEPT. ’07 $ $ $ $ $ they continue to dedicate toward drawn more than 200,000 views, 42.1 38.8 32.9 32.3 31.0 innovating and how much do they many of them from behind the 2006 $ $ $ $ $ retrench back toward basics?” site’s “adults-only” curtain. 41.0 60.0 30.3 47.3 36.1 Mr. Perkins, corporate VP-cor- Rembrandt also got more porate affairs, isn’t entertaining measured-media support than CREATIVE JWT ALCHEMY MOTHER JWT DDB such doubts. “We’re really happy ever—$22 million through the AGENCY with the progress we’re making, third quarter of 2007 compared and we’re going to continue to with only $10.5 million for all of forge ahead with innovative pro- 2006. grams and raising the bar on cre- The effort won Mother inter- ativity—full speed ahead.” nal awards from J&J and the big- He points to a long list of ger-spending K-Y “sexual health” accomplishments in the past year brand account last summer. or so, including a global media What it didn’t win was many review, a new communications- consumers. Rembrandt’s whiten- planning system and global spon- ing-product sales plunged 32% sorship of the 2008 Summer last year to $21.7 million, accord- BRAND Olympics in Beijing. ing to Information Resources Inc. ONE TOUCH ACUVUE SPLENDA NEOSPORIN REMBRANDT Meanwhile, Listerine has fared STRIKE-STRICKEN far better with the more-conven- JAN.-SEPT. ’07 $ $ $ $ $ But the writers strike has raised the tional launch of its self-dissolving 29.9 26.8 23.5 22.4 22.0 price of one of J&J’s key marketing whitening strips from the more- 2006 $ $ $ $ $ shifts: VP-Global Media Kim conventional agency brought into 38.2 26.1 34.5 22.4 10.5 Kadlec’s move to sit out the TV the J&J fold via the deal, WPP upfront. The strike has dried up Group’s JWT, New York. CREATIVE DDB MCCANN BBDO JWT MOTHER available ratings points and driven The Listerine strips, launched AGENCY ERICKSON up scatter prices. Companies such in March, racked up $19.1 million as Unilever that mulled a pullback in sales last year and surpassed but ultimately participated in the Rembrandt in its core category in upfront can get make-goods that the fourth quarter. While Listerine J&J doesn’t get. picked up a 7.9% share for 2007 in That, in turn, could make it whitening, Rembrandt gave back harder to deliver on savings hoped 5.7 of those points. for from J&J’s U.S. media-buying J&J reported last week that the consolidation last year. According double-digit sales growth delivered to people familiar with the compa- by Listerine was offset by declines ny, it could also rankle executives in Rembrandt and Reach tooth- BRAND who came in from Pfizer, where brushes. So essentially, the biggest ROC STAYFREE BAND-AID VISINE MONISTAT nearly 90% of budgets went into jewel in the Pfizer deal saw its gains TV. Should brands fail to meet mostly wiped out by Rembrandt. JAN.-SEPT. ’07 $ $ $ $ $ sales plans, the media strategy J&J declined to comment on 17.5 17.0 15.8 15.7 14.2 could become an easy scapegoat. Rembrandt, but Mr. Perkins said: 2006 $ $ $ $ $ The incoming Pfizer executives “We really think we’ve moved the 21.7 19.0 16.0 25.7 19.3 already have shown an aversion to needle on innovation and creativi- some of the new approaches J&J ty, and we’re not going to stop. … CREATIVE DDB BBDO JWT JWT BBDO has been trying. At least two non- The world is changing, and we AGENCY traditional campaigns that had need to change with it.” 1. Includes children’s Tylenol Source: TNS Media Intelligence.
Recommended publications
  • 2019 Health for Humanity Report
    2019 Health for Humanity Report Progress in Sustainability Report Summary Contents Message from Our Chairman and CEO 3 Sustainability Approach 4 2019 Year in Brief 5 Better Health for All: Tackling the World’s 6 Toughest Health Challenges Better Health for All: Access, Community 7 Health & Innovation Responsible Business Practices 8 Environmental Health 9 UNICEF, the Government of Vietnam and Johnson & Johnson are partnering on a national program to train more than 500 ethnic minority midwives in remote regions to provide effective maternal and child health interventions including early essential newborn care in village clinics and homes. Photo by Paul Bettings Front cover Volunteers, frontline health workers and government officials at the launch of the Umurinzi vaccination program in Rwanda. In October 2019, Johnson & Johnson committed to donating up to 700,000 regimens of Janssen’s investigational Ebola vaccine to support the Ebola outbreak response in Rwanda and the Democratic Republic of the Congo. Photos by Rwanda Ministry of Health 2019 Health2017 for Health Humanity for HumanityReport Summary Report 33 Message from Our Chairman and CEO Dear Johnson & Johnson Stakeholders, We know this mission will always be unfinished, and affirmed unequivocally that there is a fundamental that we will occasionally fall short. But that only serves connection between serving all stakeholders and 2019 was a year of profound change and great contrasts as motivation to move faster than we’ve ever moved generating sustainable, long-term value. around the globe. before in making bigger strides toward some of our most ambitious goals. And as we’ve detailed in this Report, we The demands for global healthcare and responsible We saw unprecedented innovation and encouraging have plenty of positive momentum worth recognizing.
    [Show full text]
  • 2015 Annual Report
    ANNUAL REPORT 2015 MARCH 2016 TO OUR SHAREHOLDERS ALEX GORSKY Chairman, Board of Directors and Chief Executive Officer This year at Johnson & Johnson, we are proud this aligned with our values. Our Board of WRITTEN OVER to celebrate 130 years of helping people Directors engages in a formal review of 70 YEARS AGO, everywhere live longer, healthier and happier our strategic plans, and provides regular OUR CREDO lives. As I reflect on our heritage and consider guidance to ensure our strategy will continue UNITES & our future, I am optimistic and confident in the creating better outcomes for the patients INSPIRES THE long-term potential for our business. and customers we serve, while also creating EMPLOYEES long-term value for our shareholders. OF JOHNSON We manage our business using a strategic & JOHNSON. framework that begins with Our Credo. Written OUR STRATEGIES ARE BASED ON over 70 years ago, it unites and inspires the OUR BROAD AND DEEP KNOWLEDGE employees of Johnson & Johnson. It reminds OF THE HEALTH CARE LANDSCAPE us that our first responsibility is to the patients, IN WHICH WE OPERATE. customers and health care professionals who For 130 years, our company has been use our products, and it compels us to deliver driving breakthrough innovation in health on our responsibilities to our employees, care – from revolutionizing wound care in communities and shareholders. the 1880s to developing cures, vaccines and treatments for some of today’s most Our strategic framework positions us well pressing diseases in the world. We are acutely to continue our leadership in the markets in aware of the need to evaluate our business which we compete through a set of strategic against the changing health care environment principles: we are broadly based in human and to challenge ourselves based on the health care, our focus is on managing for the results we deliver.
    [Show full text]
  • Frequently Asked Questions
    Frequently Asked Questions Why are these companies included on the "Do Test" list? The following companies manufacture products that are tested on animals at some stage of development. Those marked with a Ƈ are currently observing a moratorium on (i.e., current suspension of) animal testing. Please encourage them to announce a permanent ban. Listed in parentheses are examples of products manufactured by either the company listed or, if applicable, its parent company. For a complete listing of products manufactured by a company on this list, please visit the company's website or contact the company directly for more information. Companies on this list may manufacture individual lines of products that have not been tested on animals. They have not, however, eliminated tests on animals for their entire line of cosmetics and household products. What if a company isn't on either of PETA's lists? Some companies have refused to respond to specific questions about their testing practices. It appears likely that these companies do test on animals at some stage of product development, and their refusal to clarify their testing policies appears to be an attempt to mislead consumers. Other companies may be new. If you find a company not included on our lists, please share the company's contact information with PETA so that we can contact the company directly. Legend Ƈ The company is currently observing a moratorium on animal testing. 3M 3M Corporate 1-888-364-3577 www.solutions.3m.com Headquarters 3M Center St. Paul, Minnesota 55144-1000 Acuvue (Johnson & Johnson) Customer (800) 843-2020 www.acuvue.com/ Relations, D-QA 7500 Centurion Parkway Jacksonville, Florida 32256 Aim (Church & Dwight) P.O.
    [Show full text]
  • Creative Director 561.714.1585 Andy Mathurin
    Hello, I am: Looking for role as: Let’s Connect: Andy Mathurin Creative Director 561.714.1585 Associate Creative Director, [email protected] Brand Strategist New York What I do: PROFILE Brand Strategy Over 8 years leading branding and marketing concepts with career spanning 360 campaigns, broadcast, print, OOH, social, digital, video and experiential Identity Design across major worldwide brands. Energetic and a creative visionary offering Storytelling demonstrated expertise in all aspects of branding and strategy, with core focus Thought Leader on delivering business results. Team Builder Marketing WINS Project Management Successes have included winning several accounts for new business, resulting in agency being awarded Global Agency of the Year by AdAge & Adweek. Toolkit: AOR: Havas - Vascepa 2019, Havas - Alcon 2019, J3 - OGX 2018, UM - H&M 2017, UM - Sony 2017, BMW 2016, UM - Coca Cola 2016 Sketch XD Microsoft Office PROFESSIONAL EXPERIENCE Avocode 03.18 HAVAS | Manhattan, NY Photoshop Present Associate Creative Director Strategic partner, focusing on brand equity for healthcare and InDesign pharmaceutical brands. Responsible for new business and leading creative Illustration team/studio across all digital platforms (specializing in social). After Effects Brands include: Zicam, Alcon, GSK, NUCALA, TRELEGY, & ANORO. 09.14 Universal McCann Worldwide | Manhattan, NY 03.18 Personality: Associate Creative Director + Senior Art Director Hands-on leader in identity design. Champion participant in winning new Human business pitches. Guiding and advising clients on high-level executions. Confident Brands include: Sony Pictures, GoPro, McCormick, BMW... and more. Effective Communicator - Demonstrate strong leadership overseeing staff in the day-to-day projects Motivational Honest with Integrity - Deliver against demanding brand objectives and develop creative that Empathetic exceeds business needs, managing projects from concept through completion: timelines, budgets, schedules, etc.
    [Show full text]
  • Ethics and Social Responsibility
    Fundamentals of Business, Second Edition Chapter 4 Ethics and Social Responsibility Content for this chapter was adapted from the Saylor Foundation’s http://www.saylor.org/site/textbooks/Exploring%20Business.docx by Virginia Tech under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License. The Saylor Foundation previously adapted this work under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License without attribution as requested by the work’s original creator or licensee. If you redistribute any part of this work, you must retain on every digital or print page view the following attribution: Download this book for free at: http://hdl.handle.net/10919/84848 Lead: Stephen J. Skripak Contributors: Anastasia Cortes, Gary Walton, Anita Walz Digital and Print Production: Corinne Guimont with Robert Browder Alternative Text and Accessibility: Stephanie Edwards, Christa Miller, and Corinne Guimont Selected graphics: Brian Craig Cover design: Trevor Finney Student Reviewers: Jonathan De Pena, Nina Lindsay, Sachi Soni Project Manager/Editor: Anita Walz This chapter is licensed with a Creative Commons Attribution-Noncommercial-Sharealike 3.0 License. Download this book for free at: http://hdl.handle.net/10919/84848 VT Publishing, a division of the University Libraries at Virginia Tech August 2018 4. Chapter 4 Ethics and Social Responsibility Learning Objectives 1. Define business ethics and explain what it means to act ethically in business. 2. Explain why we study business ethics. 3. Identify ethical issues that you might face in business, such as insider trading, conflicts of interest, and bribery, and explain rationalizations for unethical behavior. 4. Identify steps you can take to maintain your honesty and integrity in a business environment.
    [Show full text]
  • Lna 2006 Profiles J.Qxp
    1 | Advertising Age | June 26, 2006 SpecialSpecial ReportReport:100 Profiles LEADING NATIONAL ADVERTISERSSupplement SUPPLEMENT June 26, 2006 100 LEADING NATIONAL ADVERTISERS Profiles of the top 100 U.S. marketers in this 51st annual ranking INSIDE TOP 100 RANKING COMPANY PROFILES SPONSORED BY The nation’s leading marketers Lead marketing personnel, ranked by U.S. advertising brands, agencies, agency expenditures for 2005. contacts, as well as advertising Includes data from TNS Media spending by media and brand, Intelligence and Ad Age’s sales, earnings and more for proprietary estimates of the country’s 100 largest unmeasured spending. PAGE 8 advertisers PAGE 10 This document, and information contained therein, is the copyrighted property of Crain Communications Inc. and The Ad Age Group (© Copyright 2006) and is for your personal, non-commercial use only. You may not reproduce, display on a website, distribute, sell or republish this document, or information contained therein, without prior written consent of The Ad Age Group. Are proud to connect you with the leading CMOs See all the interviews at adage.com/point LAUNCHING JUNE 28 © 2006 Crain Communications Inc. www.adage.com 3 | Advertising Age | June 26, 2006 Special Report 100 LEADING NATIONAL ADVERTISERS SUPPLEMENT ABOUT THIS PROFILE EDITION THE 51ST ANNUAL 100 Leading National the Top 100 ($40.13 billion) and for all measured spending in 18 national media, Advertisers Report crowned acquisition- advertisers ($122.79 billion) in the U.S. Yellow Pages Association contributed ladened Procter & Gamble Co. as the top U.S. ad spending by ad category: This spending in Yellow Pages and TNS Marx leader, passing previous kingpen General chart (Page 6) breaks out 18 measured Promotion Intelligence provided free- Motors Corp.
    [Show full text]
  • Lifescan Ethicon
    LouiseLouise MehrotraMehrotra ViceVice PresidentPresident InvestorInvestor RelationsRelations ““SafeSafe HarborHarbor”” StatementStatement This presentation may contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from the Company. The Company does not undertake to update any forward-looking statements as a result of new information or future events or developments. WilliamWilliam C.C. WeldonWeldon ChairmanChairman ofof thethe BoardBoard && ChiefChief ExecutiveExecutive OfficerOfficer TodayToday’’ss AgendaAgenda
    [Show full text]
  • Annual Report
    ANNUAL REPORT 2019 MARCH 2020 To Our Shareholders Alex Gorsky Chairman and Chief Executive Officer By just about every measure, Johnson & These are some of the many financial and Johnson’s 133rd year was extraordinary. strategic achievements that were made possible by the commitment of our more than • We delivered strong operational revenue and 132,000 Johnson & Johnson colleagues, who adjusted operational earnings growth* that passionately lead the way in improving the health exceeded the financial performance goals we and well-being of people around the world. set for the Company at the start of 2019. • We again made record investments in research and development (R&D)—more than $11 billion across our Pharmaceutical, Medical Devices Propelled by our people, products, and and Consumer businesses—as we maintained a purpose, we look forward to the future relentless pursuit of innovation to develop vital with great confidence and optimism scientific breakthroughs. as we remain committed to leading • We proudly launched new transformational across the spectrum of healthcare. medicines for untreated and treatment-resistant diseases, while gaining approvals for new uses of many of our medicines already in the market. Through proactive leadership across our enterprise, we navigated a constant surge • We deployed approximately $7 billion, of unique and complex challenges, spanning primarily in transactions that fortify our dynamic global issues, shifting political commitment to digital surgery for a more climates, industry and competitive headwinds, personalized and elevated standard of and an ongoing litigious environment. healthcare, and that enhance our position in consumer skin health. As we have experienced for 133 years, we • And our teams around the world continued can be sure that 2020 will present a new set of working to address pressing public health opportunities and challenges.
    [Show full text]
  • Palm Oil Shopping Guide: Current Best Choices
    FOOD Brand Names of FOOD Brand Names of FOOD Brand Names of FOOD Brand Names of FOOD Brand Names of Make a Difference RSPO Members RSPO Members RSPO Members RSPO Members RSPO Members for Wild 3 Musketeers Cinnamon Toast Crunch Honey Maid Grahams Mothers Cookies Splenda Orangutans Act II Coffee Mate Hot Pockets Mountain High Yogurt Starburst Adam's PB Country Crock Hungry Jack Muffin Mam Pastries Stouffers Almond Joy Country Time Hunt's Muir Glen Trident Gum BOYCOTTING PALM Altoids Crisco International Delight Nabisco Sun Chips OIL IS NOT THE Arnott's Biscuits Crunch and Munch Jenny Craig Meals Nature Valley SuperMoist Cake Mixes SOLUTION… Aunt Jemima Foods Dean's Dips Jeno's Pizza Near East Sweet Rewards Bars Austin Brand Crackers Doritos Jif PB Nerds Sweet Tarts Supporting Baby Ruth Dove Chocolates Jiffy Pop Nesquik Swiss Miss companies that are Bac Os Dreyer's Jolly Ranchers Nestle Products Tombstone Pizza members of the Baker's Chocolate Edy's Justin's NutButter Nutter Butter Cookies Tostitos RSPO (Roundtable on Balance Bars Egg Beaters Justin's PB Cups Old El Paso Total Cereal Sustainable Palm Oil) Banquet Meals Endangered Species Choc. Keebler Cookies Oreo Cookies Totino's Pizza is the most Barilla Famous Amos Cookies Keebler Crackers Orville Redenbacher's Trix Cereal responsible solution. BelVita Fiber One Products Kellogg's Products Pam Tuna Helper Ben & Jerry's Ice Cream Fleischmann's Kid Cuisine Parent's Choice Twix Bertolli Frito Lay Kit Kat Parkay Twizzlers For more information Betty Crocker products Folgers Kix Cereal Pasta
    [Show full text]
  • 2016 Annual Report
    ANNUAL REPORT 2016 MARCH 2017 TO OUR SHAREHOLDERS ALEX GORSKY Chairman and Chief Executive Officer I’ve worked in the health care industry for Rather, true innovations are the result of WE ARE UNITED nearly 30 years. It’s been both an honor and collaboration. And that collaboration is AND INSPIRED a privilege to work for Johnson & Johnson, driven by a diversity of ideas, individuals BY OUR CREDO, a company that touches the lives of over and disciplines – working together toward WHICH RINGS a billion people every day, around the a common goal. AS TRUE TODAY world. As I look at today’s health care AS IT DID WHEN landscape, it’s incredibly clear that the Today, more than ever, the world needs IT WAS WRITTEN pace of change has never been greater, leaders who are committed to working MORE THAN 70 or frankly, more exciting. together to help bring improved health YEARS AGO. and wellness to every person in every Today’s rapid change brings both corner of the globe. As the world’s largest opportunities and risks for any company and most broadly based health care in health care, and we are prepared company, we are uniquely positioned to help to address both. There are significant transform global health care; to shine a light challenges to overcome, but the tools, the on the most important issues we are facing; insights, the technologies, the innovations to collaborate across boundaries and – both evolutions and revolutions – all borders; to uncover scientific insights and combine to make today one of the most ideas; and to dedicate resources towards promising times for human health and for creating tomorrow’s breakthroughs.
    [Show full text]
  • 2012 Citizenship & Sustainability Report
    2 012 Citizenship & Sustainability Report Contents About this Report ......................3 Environmental Impacts ................. 26 Culture of Health Program Global Reporting Initiative (GRI) ........3 Environmental, Health and Safety Provision and Innovation ........... 50 Feedback and Further Information .......3 Management Approach............... 26 Employee Health Goals .............. 50 Goal Setting ....................... 26 Lifestyle and Population Health ...... 51 Letter from the Chairman Organizational Responsibility .... 26 Mental Well-Being .................... 52 and Chief Executive Officer ..........4 Management Systems and Workplace Health Protection ........ 52 Successes & Challenges ..............6 Standards ........................ 27 Globally Harmonized Training ............................. 27 Health Policies .................... 52 Company Profile ........................9 Environmental Compliance ........... 27 Health Outcomes and Impacts ...... 53 Our Brands ................................9 Climate Change ....................... 27 Anti-Counterfeiting ...................... 53 Operational Structure ....................9 Climate Policy Initiatives ......... 27 Significant Changes During the Workplace Health and Safety .......... 53 Facility CO2 Emissions ........... 28 Reporting Period ..................... 10 Contractors ............................ 55 Transportation-Related Fleet Safety ........................... 55 Governance & External CO2 Emissions .................. 31 Commitments ........................
    [Show full text]
  • Gelatina Di K-Y Da Wikipedia, L'enciclopedia Libera Salto A: Navigazione, Ricerca
    Gelatina di K-Y Da Wikipedia, l'enciclopedia libera Salto a: navigazione, ricerca /wiki/Image:K-Y.jpg/wiki/Image:K-Y.jpg /wiki/Image:K-Y.jpgUn tubo della gelatina di K-Y La gelatina di K-Y, anche conosciuta come la gelatina di Panitsa, è un lubrificante personale a base d'acqua e solubile in acqua prodotto da Johnson & Johnson. Le iniziali “K-Y„ non sono conosciute per rappresentare alcune parole - sono state descritte dal loro creatore come “lettere arbitrarie„ - ma sono mantenute per la loro marca- identità. È stato introdotto nel gennaio 1904 dal creatore Van Horn & Sawtell del suturare e farmaceutico di New York City, [1] e più successivamente acquistato da Johnson & Johnson, scopo dichiarato originale della gelatina di K-Y come lubrificante chirurgico ed è stato scelto spesso dai medici a causa della relativa base vegetale. Il prodotto ora è più ampiamente usato come lubrificante sessuale. Non reagisce con i condoms del lattice o il silicone gomma-ha basato i giocattoli del sesso. Mentre non suggerito per ingestione, ha un gusto dello sweetish, in modo da non interferire con il sesso orale. Ha una consistenza spessa e una tendenza asciugarsi durante l'uso, ma può “essere riattivato„ tramite l'aggiunta della saliva o di più acqua. La gelatina di K-Y non contiene uno spermicide. Una formulazione con nonoxynol-9 era disponibile, ma Johnson & Johnson lo ha tirato dal mercato dopo l'individuazione che potrebbe aiutare il HIV a spargersi. [2] Il prodotto può anche essere usato per gli scopi di lubrificazione quando prende la temperatura corporea dal retto.
    [Show full text]